<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04874116</url>
  </required_header>
  <id_info>
    <org_study_id>R01HL149777-01A1</org_study_id>
    <nct_id>NCT04874116</nct_id>
  </id_info>
  <brief_title>Decreasing Cardiovascular Risk for Patients With Diabetes</brief_title>
  <official_title>Improving Diabetic Patients' Adherence to Treatment and Prevention of Cardiovascular Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Michigan State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Michigan State University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiovascular disease (CVD) complications are the leading cause of diabetes mellitus&#xD;
      (DM)-related morbidity and mortality, creating a significant burden on the public health&#xD;
      system. This burden is, in part, attributable to poor medication adherence, with 21-42% of&#xD;
      patients failing to properly adhere to their care. Importantly, this issue is especially&#xD;
      pronounced in minority and low-income populations, which show higher rates of chronic illness&#xD;
      and lower medication adherence. Interventions that foster and reinforce patient-centered&#xD;
      communication between clinicians and patients show promise in improving health outcomes.&#xD;
      However, they have not been widely implemented, in part due to a lack of compelling evidence&#xD;
      for their effectiveness in primary care settings. Project Objective: The investigators&#xD;
      propose to evaluate the impact of a patient activation program: Office Guidelines Applied to&#xD;
      Practice (Office-GAP) combined with mobile text messaging reinforcement (Way to Health [W2H])&#xD;
      on medication adherence in patients with DM compared to mobile texting alone. Office-GAP&#xD;
      incorporates shared decision-making and a decision/support checklist to be completed during&#xD;
      office visits, to foster patients' investment in their own care. W2H is a texting service&#xD;
      that informs and encourages patients to adhere to goals and improve communication. The&#xD;
      long-term goal is to develop a model that can reliably improve and sustain adherence and can&#xD;
      be successfully implemented in primary care clinics to close the morbidity and mortality gap&#xD;
      for minority/low-income DM patients. The hypothesis is that the combined face-to-face patient&#xD;
      activation and texting- delivered reinforcement methods will facilitate communication between&#xD;
      patients and providers, improving the frequency, accuracy, and timeliness of communication&#xD;
      while reinforcing shared goals and engendering mutual respect more than texting alone.&#xD;
      Improved communication between patients and providers may improve medication adherence, blood&#xD;
      sugar, cholesterol, blood pressure control, and patient satisfaction with providers, and&#xD;
      ultimately decrease burden of illness.&#xD;
&#xD;
      Research Strategy: The investigators will conduct a randomized community-based clinical trial&#xD;
      in Federally-Qualified Health Centers (FQHCs) in Michigan enrolling 378 patients in 17 teams.&#xD;
      All patients will receive usual care and medication for DM and CVD prevention. Eight teams&#xD;
      will use W2H alone, and 9 teams will combine Office-GAP with WTH. The investigators will&#xD;
      evaluate the impact of shared decision-making strategies for patients and providers.&#xD;
&#xD;
      Impact: If successfully translated to clinical practice, these interventions have the&#xD;
      potential to significantly impact patient care in FQHCs, improving outcomes for DM and CVD.&#xD;
      This research also paves the way for shifting clinical practice across a spectrum of chronic&#xD;
      disease where medication non-adherence is an issue.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study design and overview: The investigators will conduct this study with 17 teams in 12&#xD;
      clinics that serve low-income patients: Federally Qualified Health Centers (FQHC's). The goal&#xD;
      of the study is to evaluate how well the approach to improving patient outcomes with a blend&#xD;
      of communication strategies works in real-world settings compared to mobile phone texting&#xD;
      alone. Each team will be randomly assigned to one of two groups: the Intervention (Group 1):&#xD;
      includes a patient group meeting + a checklist used during each medical visit (together&#xD;
      called Office-GAP) along with text messaging in between visits; the Control (Group 2)&#xD;
      includes only the text messages.&#xD;
&#xD;
      Randomization: The investigators will recruit 22 diabetes (DM) patients per team. All&#xD;
      patients at a particular team will participate in the same group (intervention or control).&#xD;
      The investigators chose this approach because it is realistic for providers and patients at a&#xD;
      team to follow a similar approach. This also helps the comparison of control and intervention&#xD;
      groups to be more accurate because there is less chance of mixing between the two groups. In&#xD;
      Michigan, FQHCs have similar numbers and types of providers (internal and family medicine)&#xD;
      and nurse practitioners.&#xD;
&#xD;
      Methods. Setting: Because the investigators are interested in how well the interventions may&#xD;
      address disparities in health outcomes for low-income and minority patients, they are&#xD;
      recruited from FQHCs who serve these populations in Michigan. FQHC patients are mainly below&#xD;
      federal poverty levels (92% of participants); 56% are non-white; 91% are uninsured or covered&#xD;
      by Medicaid. Sample: A total of 378 patients, men and women, with Type II diabetes that is&#xD;
      not well-controlled (the standard will be a score for the HbA1c test equal to or higher than&#xD;
      8) will be recruited. In the investigators' pilot studies, 80% of patients who met these&#xD;
      criteria agreed to participate. In the pilot, about 10% dropped out before follow-up at 3&#xD;
      months and a further 3% dropped out before completion. A 20% dropout rate is anticipated.&#xD;
      Recruiting 378 patients will result in 320 patients retained by the end of the 5 year study.&#xD;
      Based on the pilot study and feedback from clinics, it is estimated that the enrollment goal&#xD;
      will be reached within 4 years. Each FQHC will have at least 200 DM patients who meet the&#xD;
      criteria.&#xD;
&#xD;
      Patient Intervention procedures: Patients will participate either in the intervention group&#xD;
      (Office-GAP + Texting) or in the control group (Texting only) as described below. All&#xD;
      patients will receive medical treatment-as-usual from the participating clinics, consisting&#xD;
      of diabetes care, usual preventive care, and other medical treatment as needed.&#xD;
&#xD;
      Office-GAP Intervention (Patient Activation Intervention): The investigators have described&#xD;
      the Office-GAP intervention in previous peer-reviewed publications (1-3). Briefly, after&#xD;
      recruitment, patients in the Office-GAP group will attend: 1) one scheduled group visit,&#xD;
      (90-120 min; 4-6 patients at a time); 2) one follow-up visit with their providers within one&#xD;
      month, and then at 3, 6, 9, and 12 months after the group visit. At these follow-up visits,&#xD;
      providers will complete the Office-GAP Checklist, which evaluates medication prescribing&#xD;
      behavior. In addition, shared decision-making (SDM) and goal setting occurs between patient&#xD;
      and provider. These follow-up visits are patients' regularly scheduled visits with their&#xD;
      providers and not additional to their usual care.&#xD;
&#xD;
      At the group visit: Research Assistants will obtain informed consent/HIPAA authorization from&#xD;
      patients after introducing them to the study; Group 1: Office-GAP + Texting session: the&#xD;
      group visit is a Shared Decision Making (SDM) activation session wherein patients learn&#xD;
      self-management behaviors, communication skills, and use of decision support tools (DSTs).&#xD;
      They also learn how to use the eCap electronic pill container to monitor medication&#xD;
      adherence; learn to use Way to Health Texting service and confirm set up on their mobile&#xD;
      phone. Group 2: For the texting only group: participants will learn how to use Way to Health&#xD;
      Texting service and confirm set up on their mobile phone, and learn how to use the eCap&#xD;
      electronic pill container to monitor medication adherence. They will not experience the&#xD;
      Office-GAP intervention. Both groups will also complete baseline study questionnaires during&#xD;
      the group visit.&#xD;
&#xD;
      Office-GAP Follow-up visit with providers: the Office-GAP Checklist. The Office-GAP Checklist&#xD;
      is the core tool of the SDM intervention. A one-page checklist, this SDM tool outlines all&#xD;
      evidence-based medications for secondary prevention of cardiovascular disease (CVD) in T2DM&#xD;
      patients. It is an in-consultation decision support tool that helps engage the patient and&#xD;
      provider to encourage and enhance an SDM process via discussion of medication and secondary&#xD;
      prevention/lifestyle changes during an office visit. In this study, the Office-GAP Checklist&#xD;
      will be completed by the provider with direct patient involvement during the office visits at&#xD;
      0-1, 3, 6, 9 and 12 months. Only Group 1 patients will use this checklist during their office&#xD;
      visits.&#xD;
&#xD;
      The Office-GAP Checklist also serves as a provider reminder at the point of care, because the&#xD;
      provider records a check-mark for each medication: &quot;Yes&quot; (if patient is on the medication),&#xD;
      &quot;No&quot; (if patient is not), or &quot;Does not apply to me becauseâ€¦&quot; A reason for exclusion of a&#xD;
      medication is also provided (patient is not eligible for the medication, has a&#xD;
      contraindication to its use, or the patient and provider have identified an alternative due&#xD;
      to side effect or cost concerns). Details about the next appointment and any secondary&#xD;
      prevention plan changes are also listed on the form. At the end of the visit, both patient&#xD;
      and provider sign the form to confirm that they have reviewed the checklist. The patient&#xD;
      receives a copy of the checklist to take home and a copy is retained in the patient record.&#xD;
      All providers in the intervention teams receive a brief provider education in Office-GAP tool&#xD;
      use and communication skills (described below C.4.15).&#xD;
&#xD;
      Educational tool literacy standards. Office-GAP has been rigorously adapted for use with low&#xD;
      health literacy patients. All study materials are grade 6 reading level.&#xD;
&#xD;
      Mobile DM self-management texting intervention (Way to Health Texting Program). During group&#xD;
      visits, all patients in both groups will be taught how to send and receive text messages on&#xD;
      their phone. The Way to Health service does not require patients to use a special app. Way to&#xD;
      Health engages patients in two ways: 1) Patients receive daily Way to Health messages&#xD;
      appropriate to their diagnosis and medications (e.g. BP, blood glucose, medication) and&#xD;
      appointment reminders throughout the study. They also receive informational and educational&#xD;
      texts. 2) Patients respond to prompts, and may contact their providers' office throughout the&#xD;
      study via texting. Patients will receive additional diabetic modules that follow the standard&#xD;
      for diabetes education for the rest of the 12 months once the initial 15 week program is&#xD;
      complete. The Way to Health texting program will be used to encourage T2DM patients to&#xD;
      maintain communication with their providers, improve medication adherence, and other&#xD;
      secondary prevention and self-care between visits. Daily messages may take the form of&#xD;
      reminders, prompts, education, or reinforcement. Sample message texts include &quot;Did you take&#xD;
      your medications today?&quot; and &quot;How many times did you check your feet for wounds this week?&quot;&#xD;
      The pilot found the program to be usable and effective for both patients and providers.&#xD;
&#xD;
      Provider and Practice Staff Training. All intervention providers will participate in an&#xD;
      interactive orientation which has been shown to promote behavioral change among health&#xD;
      professionals. Providers will be asked to agree to participate in the study before the&#xD;
      session. Provider/Staff Educational module: The training session is 90 minutes long. The&#xD;
      session is scheduled at multiple times to meet providers' needs. In the pilot Office-GAP&#xD;
      study, there was 100% participation by providers. The training module, delivered by the PI&#xD;
      and Dr. Karen Kelly-Blake, includes: 1) brief presentations on effectiveness and&#xD;
      cost-effectiveness of medical therapy and behavior changes in management of T2DM, blood&#xD;
      pressure, and heart disease; 2) a hands-on practice session for providers to elicit patients'&#xD;
      preferences and values; 3) an introduction to the Office-GAP Checklist and best practices for&#xD;
      using it during a patient encounter; 4) review of the Smith evidence-based patient-centered&#xD;
      method for establishing trust, communicating clearly, and engaging in goal-setting with&#xD;
      patients. Providers will have a chance to practice skills using Braddock and Elwyn's approach&#xD;
      to role-playing to model office visits; and 5) a complete pre-and post-training survey&#xD;
      (before and after the training session) to determine provider attitudes about the use of&#xD;
      DSTs, SDM, and mHealth in their practice and an end of study semi-structured interview. The&#xD;
      investigators are highly experienced in provider training.&#xD;
&#xD;
      Analysis of outcomes: The primary outcome (medication adherence - how well patients adhere to&#xD;
      their providers' advice to take medications) will be assessed in each individual patient by&#xD;
      e-CAP monitoring, a device that signals when patients open their prescription medication&#xD;
      bottles. The investigators will conduct preliminary analysis of study hypotheses at 6mo and&#xD;
      12mo using standard statistical tests. A comparison of Office-GAP plus Way to Health teams&#xD;
      (Group 1) to Way to Health only teams (Group 2) at baseline will be conducted to be sure the&#xD;
      patient populations are similar in terms of health characteristics that may influence the&#xD;
      results. If substantive differences are found, the investigators will be able to control for&#xD;
      these in subsequent analyses using statistical regression techniques. This method assures a&#xD;
      degree of dissimilarity rather than assuming all of the clinical populations are identical.&#xD;
      Equivalence between the groups will be assessed based on demographic factors such as age,&#xD;
      gender, education, race/ethnicity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 26, 2021</start_date>
  <completion_date type="Anticipated">April 2025</completion_date>
  <primary_completion_date type="Anticipated">April 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Office-GAP is a Patient Activation Intervention Program for Group 1 that includes: 1) Group visit 2) Provider training for patient activation, and 3) Office-GAP checklist used in the office. Patients in Groups 1 and 2 will attend one group visit and 5 follow-up visits with their provider in 1 month, 3, 6, 9 and 12 months after the group visit. For Group 1, the group visit is a shared decision making (SDM) activation session wherein patients learn self-management behaviors, medication use, communication skills, and use of decision support tools (DST). The Office-GAP Checklist is an in-consultation DST that helps engage the patient and provider in initiating and enhancing a SDM process via discussion of medication and secondary prevention/lifestyle changes. Way to Health is a text-based DM self-management program. Groups 1 and 2 receive a 15-week customized program of text messages after the group visit. For the remaining 12 months, they will receive standard diabetic education modules.</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Medication adherence</measure>
    <time_frame>Progression of adherence over 12 months</time_frame>
    <description>eCAP records real-time adherence data, tracking each opening with date and time</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Medication adherence</measure>
    <time_frame>Progression of adherence over 12 months</time_frame>
    <description>Adherence to Refills and Medication (ARMs).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Medication Adherence</measure>
    <time_frame>Progression of adherence over 12 months</time_frame>
    <description>Survey to assess medication adherence</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in UK Prospective Diabetes Study (UKPDS)</measure>
    <time_frame>Progression of risk over 12 months</time_frame>
    <description>Diabetes-specific 10-year CVD and stroke risk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Patient activation measure</measure>
    <time_frame>Progression of activation model over 12 months</time_frame>
    <description>13-item scale that reflects a developmental model of activation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in CollaboRATE</measure>
    <time_frame>Progression of shared decision-making over 12 months</time_frame>
    <description>Measures level of shared decision-making in clinical encounter from patient's perspective. 3-question survey. Scale of 1 = no effort was made to 10 = every effort was made. Higher score indicates higher measure of shared decision-making between patient and provider.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">378</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Office Guidelines Applied to Practice (Office-GAP) + mobile phone text messaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive Office Guidelines Applied to Practice (Office-GAP) + mobile phone text messaging for 12 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mobile phone text messaging</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants receive mobile phone text messaging alone for 12 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Office Guidelines Applied to Practice (Office-GAP) + Mobile text messaging</intervention_name>
    <description>Office-GAP incorporates shared decision-making and a decision/support checklist to be completed during office visits, to foster patients' investment in their own care. Way to Health is a cell phone messaging service that informs and encourages patients to adhere to goals and improve communication.</description>
    <arm_group_label>Office Guidelines Applied to Practice (Office-GAP) + mobile phone text messaging</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mobile text messaging</intervention_name>
    <description>Way to Health is a cell phone messaging service that informs and encourages patients to adhere to goals and improve communication.</description>
    <arm_group_label>Mobile phone text messaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients: aged &gt;18 at participating Federally Qualified Health Care centers (FQHCs) and; 1)&#xD;
        have a diagnosis of Type 2 diabetes (T2DM) with HbA1c &gt;8, with or without CVD; 2) patient&#xD;
        should be taking at least one prescribed medication for BP or cholesterol management 3)&#xD;
        able to provide informed consent 4) able to read and speak English (grade 6 reading level);&#xD;
        5) have a cell phone with texting (provided by our study for any enrolled patient who does&#xD;
        not have one).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1) medical record documentation of cognitive impairment, dementia or psychosis 2) plans to&#xD;
        leave the area prior to study completion 3) participating in another cellphone program.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adesuwa Olomu, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Michigan State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adesuwa Olomu, MD, MS</last_name>
    <phone>517-432-0897</phone>
    <email>olomua@msu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ingham Healthcare center</name>
      <address>
        <city>Lansing</city>
        <state>Michigan</state>
        <zip>48742</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Marshall, MD</last_name>
      <phone>989-736-8157</phone>
      <email>TMarshall@alconac.org</email>
    </contact>
    <contact_backup>
      <last_name>Bernie O'Brien, PA</last_name>
      <phone>989 471 5257</phone>
      <email>BO'Brien@alconac.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.re-aim.org</url>
    <description>Reach, Effectiveness, Adoption, Implementation, Maintenance</description>
  </link>
  <reference>
    <citation>Olomu A, Hart-Davidson W, Luo Z, Kelly-Blake K, Holmes-Rovner M. Implementing shared decision making in federally qualified health centers, a quasi-experimental design study: the Office-Guidelines Applied to Practice (Office-GAP) program. BMC Health Serv Res. 2016 Aug 2;16(a):334. doi: 10.1186/s12913-016-1603-3.</citation>
    <PMID>27484348</PMID>
  </reference>
  <reference>
    <citation>Olomu A, Khan NN, Todem D, Huang Q, Kumar E, Holmes-Rovner M. The Office Guidelines Applied to Practice program improves secondary prevention of heart disease in Federally Qualified Healthcare Centers. Prev Med Rep. 2016 Jun 29;4:357-63. doi: 10.1016/j.pmedr.2016.06.020. eCollection 2016 Dec.</citation>
    <PMID>27512651</PMID>
  </reference>
  <reference>
    <citation>Olomu A, Khan NNS, Todem D, Huang Q, Bottu S, Qadri S, Holmes-Rovner M. Blood Pressure Control in Hypertensive Patients in Federally Qualified Health Centers: Impact of Shared Decision Making in the Office-GAP Program. MDM Policy Pract. 2016 Jul 7;1(1):2381468316656010. doi: 10.1177/2381468316656010. eCollection 2016 Jul-Dec.</citation>
    <PMID>30288401</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 1, 2021</study_first_submitted>
  <study_first_submitted_qc>May 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2021</study_first_posted>
  <last_update_submitted>July 29, 2021</last_update_submitted>
  <last_update_submitted_qc>July 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Michigan State University</investigator_affiliation>
    <investigator_full_name>Adesuwa Olomu</investigator_full_name>
    <investigator_title>Swartz Endowed Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The IPD that will be shared will be related to the IPD that underlie results in a publication when requested.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>After publication of study findings in peer reviewed journals</ipd_time_frame>
    <ipd_access_criteria>Access it through the PI Dr. Ade Olomu</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

